General Anaesthesia Clinical Trial
Official title:
Comparing the Effectiveness Between Air-Q Intubating Laryngeal Airway and Ambu® AuraGain™ Laryngeal Mask for Controlled Ventilation in Paediatric Patients: A Randomized Controlled Trial.
The aim of this randomized study is conducted is to evaluate the performance and safety of air-Q intubating laryngeal airway as primary airway device in various short surgical procedure in children compared to Ambu® AuraGain™ Laryngeal Mask. Current Supraglottic airway devices (SADs) available in are classic LMA (cLMA), proseal LMA (pLMA), supreme LMA (sLMA) and the newer is Ambu® AuraGain™laryngeal mask. As variety of newer SADs for children have emerged since their introduction in clinical practice, hope the outcomes of this study it help advancing our knowledge and acumen in selecting appropriate devices for paediatric population.
JUSTIFICATION OF STUDY
In view of no clinical data is available evaluating the clinical performance and safety of
air-Q and Ambu® AuraGain™ in children, therefore this prospective and randomized study is
conducted. Most of previous randomized studies in term of safety did not compare the
hemodynamic stability.Hope the outcomes of this study it help advancing our knowledge and
acumen in selecting devices for paediatric population.
RESEARCH HYPOTHESES
1. There is no difference in the ease of insertion (number of attempts and time of
insertion) between air-Q and Ambu® Aura Gain™.
2. There is no difference in the oropharyngeal leak pressure (OLP) between air-Q and Ambu®
Aura Gain™.
3. There is no difference in hemodynamic changes between air-Q and Ambu® Aura Gain™.
4. There is no difference in the incidence of complications between air-Q and Ambu® Aura
Gain™.
METHODOLOGY
This is a prospective, single blinded and randomized controlled trial study will be conducted
at Operation Theatre (OT), Hospital University Sains Malaysia (HUSM). involving paediatric
patients scheduled for various surgical procedures within 2 hours where supraglottic airway
management would be appropriate..
Sample size calculation For objective 1, sample size was calculated using power and sample
size software and the data based on previous study by V.Darlong et al (Comparison of air-Q
and Ambu Aura-i for controlled ventilation in infants: a randomized controlled trial). In
this study, the time for successful insertion for air-Q is 16.53±1.53 and Ambu Aura-I is
14.68±2.83. Considering power of 80% and type error-I α of 5%, the sample size was required
is 15 participants in each group. 10% is added for drop out sample. Therefore sample size, n
15 + (0.1x15) = 17 participants for each group.
For objective 2, sample size was calculated using power and sample size software and the data
based on previous study by V.Darlong et al (Comparison of air-Q and Ambu Aura-i for
controlled ventilation in infants: a randomized controlled trial). In this study, the OLP for
air-Q is 20.21±4.62 and Ambu Aura-I is 16.21±5.66. Considering power of 80% and type error-I
α of 5%, the sample size was required is 22 participants in each group. 10% is added for drop
out sample. Therefore sample size, n 22 + (0.1x22) = 25 participants for each group.
Overall sample size is estimated using objective 2 because of larger sample size. Total
sample size is 50 patients.
SAMPLING METHOD Patients are randomly assigned into 2 groups: air-Q (A) and Ambu® AuraGain™
(B) using computer-generated randomization. Sequentially-numbered sealed opaque envelopes
containing group allocation as determined by computer-generated sequence, will be opened by a
nurse in charge for study device preparation.
RECRUITMENT OF SUBJECT & INFORMED CONSENT SEEKING Paediatric patients who meets the study
criteria, their parents will be approached to invite patients participate in this study. Each
parent will be given a thorough explanation along with copy of Patient Information Sheet. All
questions that the participant's parents have, will be answered to their satisfaction before
consent been obtained by signing the consent form.
The study is divided into screening, pre-operative, intra-operative and post-operative
period.
1. Screening period After obtaining approval from the Ethics committee, participants will
be selected according to inclusion and exclusion criteria during preoperative assessment
round. Study procedures will be explained and written consent will be obtained from the
participant's parents.
2. Pre-operative period In all participants, a eutectic mixture of local anaesthetic cream
(EMLA) will be applied on both hands 30 minutes before transfer to operation theatre. No
premedication will be prescribed in the morning of the surgery. All consented
participants will be randomized using computer generated randomization into two groups:
Group a (air-Q) and group B (Ambu Aura Gain). All demographic data including types and
duration of surgery and diagnosis of procedure is recorded.
3. Intra-operative Anaesthesia Technique In operation theatre, all of the participants will
be monitored with non-invasive blood pressure (NIBP), pulse oximeter (SpO2),
electrocardiogram (ECG) and capnography (EtCO2). Anesthesia is induced with sevoflurane
in oxygen. The anesthesia plane is gradually deepened by increasing the inspired
concentration of sevoflurane (2-8%) till the loss of eyelash reflex. An intravenous (IV)
cannula is inserted and intravenous fentanyl 1mcg/kg and rocuronium 0.6mg/kg are
administered. Use of neuromuscular blocking agent is to minimise the risk of reflex
activation of the airway. After 3 minutes, the appropriate size (depending upon body
weight) of SADs (according to the group allocated based on the sequence of computerized
randomization) lubricated with water soluble lubricant (KY jelly) is inserted by the
investigator by standard technique as per manufacture's recommendation. Then the cuff is
inflated and intracuff pressure is then standardized to 60 cmH20 using a digital cuff
pressure monitor. Data and timing are collected by independent observers. To prevent
biasedness in conducting the study, the same investigator will insert the device for all
participants.
Haemodynamic parameters such as blood pressure (BP), heart rate (HR), oxygen saturation
(SpO2) and end tidal carbon dioxide (EtCO2) is recorded at different interval namely,
pre induction, post induction, post insertion, every 2 minutes for 10 minutes and then 5
minutes thereafter until extubation.
Anesthesia is maintained with sevoflurane (Minimum Alveolar Concentration value of
1.0-1.2) in Oxygen: Air mixture of 50% . Pressure controlled ventilation is set and
targeting the minute ventilation to achieve normocarbia (EtCO2 35-40 mmHg).
Intra-operative analgesia is supplement by suppository paracetamol 20 mg/kg or
diclofenac sodium 1mg/kg.
Measurement of parameters
1. Attempts required to successfully insert the device is recorded
2. A successful insertion is defined as visible chest rise and a square wave trace on
the capnograph. Failure of device is labelled where need more than 3 attempts to
insert the device or alternative device is inserted or trachea is intubated.
3. The time from the picking up the device and chest rise with positive pressure
ventilation is recorded as time to insert.
4. Oropharyngeal leak pressure (OLP) is recorded by observing the peak airway pressure
at which audible leak occurred at the first time when fresh gas flow delivered at 3
litre/min and the expiratory valve is completely closed. For safety, OLP is not
allowed to exceed >40 cmH20.
5. Failure of device is also labelled if any intra-operative device repositioning or
replacement of the device due to excessive air leak or airway obstruction as
evidenced by an obstructive pattern on the capnograph leading to desaturation.
4. Post-Operative At the end of surgery, sevoflurane is turned off and 100% oxygen is
administered. Muscle relaxant is reversed by neostigmine (50 mcg/kg) and glycopyrrolate
(10 mcg/kg). With adequate tidal volume and respiratory rate, oropharyngeal suctioning
is done and the device is removed. On removal of the device, any presence of blood stain
or tongue-lip-dental trauma is recorded. In the post-operative period, the participant
is observed for any complications such as airway reflex activation (laryngospasm,
bronchospasm or severe cough), oxygen desaturation (spO2 <90%) and vomiting/aspiration.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04125121 -
Neuroplasticity Induced by General Anaesthesia
|
N/A | |
Completed |
NCT03682198 -
Neuro-Ox 2018: Assessment of Cerebral Oxygenation Under Three Clinically Relevant Conditions
|
N/A | |
Completed |
NCT04215302 -
Prediction Accuracy for Langeal Mask Unique TM Size in Pediatric Patient
|
||
Active, not recruiting |
NCT00251810 -
Can CSM Monitor Depth of Anaesthesia Just as Good as BIS?
|
N/A | |
Terminated |
NCT02013869 -
Low Flow Anaesthesia, is There a Difference Between 2 Modern Anaesthetic Machines Using Different Gas Reservoir
|
N/A | |
Completed |
NCT05681611 -
Effect of Rocuronium on BIS Values
|
||
Recruiting |
NCT01522508 -
Evaluation of Analgesia Nociception Index (ANI) During Propofol/Remifentanil and Sevoflurane/Remifentanil Anesthesia
|
N/A | |
Completed |
NCT00506246 -
Efficacy and Safety Study of Two Propofol Formulations
|
Phase 3 | |
Completed |
NCT04946110 -
Electromagnetic Stimulation of the Phrenic Nerve of Intubated Patients
|
N/A | |
Completed |
NCT02690389 -
Electro-acupuncture and Flumazenil's Effect on Sedation
|
N/A | |
Completed |
NCT02166580 -
Accuracy of CNAP PPV Under General Anaesthesia
|
N/A | |
Completed |
NCT01795482 -
Preoperative Patient Warming for Prevention of Perioperative Hypothermia in Major Abdominal Surgery
|
N/A | |
Completed |
NCT01549639 -
Blood Propofol Measurement During Anaesthesia Using Propofol Target Controlled Infusion
|
N/A | |
Completed |
NCT04771962 -
Comparison of the Anaesthetic Gases in Maintainance of General Anaesthesia in Paediatrics
|
Phase 1/Phase 2 | |
Completed |
NCT03209323 -
Epileptiform EEG Patterns During Induction of General Anaesthesia With Sevoflurane Compared to Those With Propofol
|
N/A | |
Completed |
NCT05107167 -
Electromagnetic Stimulation of the Phrenic Nerve of Intubated Patients With Obesity
|
N/A | |
Completed |
NCT06405659 -
Immediate Fever During Anaesthesia Recovery After Surgical Procedure With Scoliosis
|
||
Completed |
NCT03669484 -
Comparative Clinical Study of Efficacy and Safety of Remimazolam and Propofol in Patients Undergoing Elective Surgery Under General Anaesthesia
|
Phase 3 | |
Completed |
NCT03930966 -
Association Between a Peri-traumatic Dissociation State and the Occurrence of Post-traumatic Stress Syndrome
|
N/A | |
Completed |
NCT05789992 -
Evaluation of Equivalent Minimum Alveolar Concentration (eMAC) During Propofol/Remifentanil Anesthesia
|
N/A |